Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maribavir for CMV in Lymphoid Malignancy Patients on Bispecific Antibodies
NCT07014319Phase 2Recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Nov 2025
- Primary completion
- Oct 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of maribavir in cytomegalovirus infection (CMV), sponsored by Seoul National University Hospital. Started Nov 2025; status: recruiting.
02
Drugs
maribavir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT07014319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07014319.